{"id":12863,"date":"2020-08-06T15:00:00","date_gmt":"2020-08-06T15:00:00","guid":{"rendered":"https:\/\/wordpress2.hdnweb.com\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/"},"modified":"2020-08-06T15:00:00","modified_gmt":"2020-08-06T15:00:00","slug":"gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential","status":"publish","type":"post","link":"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/","title":{"rendered":"GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential"},"content":{"rendered":"<p><\/p>\n<style type=\"text\/css\"><![CDATA[\n\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n]]><\/style>\n<div class=\"xn-content\">\n<p><span class=\"xn-location\">LAS VEGAS<\/span>, <span class=\"xn-chron\">Aug. 6, 2020<\/span> \/PRNewswire\/ &#8212; GVB Biopharma, a pharmaceutical company specializing in hemp and cannabis-related consumer products, announced today that it has established the process and infrastructure for producing medicinal products from cannabigerol (CBG). This natural cannabinoid is a critical precursor molecule to two well-known cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD).<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n                        <a href=\"https:\/\/mma.prnewswire.com\/media\/1041447\/GVB_Logo_Biopharma_Color_Horizontal_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n                    <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1041447\/GVB_Logo_Biopharma_Color_Horizontal_Logo.jpg\" title=\"GVB Biopharma (PRNewsfoto\/GVB Biopharma)\" alt=\"GVB Biopharma (PRNewsfoto\/GVB Biopharma)\"\/><\/a>\n                <\/p>\n<\/p><\/div>\n<p>With this venture, GVB Biopharma creates a scientific foundation and professional network for a research and development program for CBG, allowing for the rapid development of licensable intellectual property. In addition to CBG, this well-vetted process can be used to identify and develop other target molecules of interest.<\/p>\n<p>The process will be established in two phases with two parts each. In the first phase, GVB will conduct extensive literature review of research on the endocannabinoid system and the effects of CBG, using the results to create an annotated database of scientific research. Next, GVB will oversee the chemical characterization of CBG, confirming the absence of pollutants and identifying important features like potency and shelf life.<\/p>\n<p>In the second phase, GVB Biopharma will create a biological characterization of CBG and assess its therapeutic potential and other meaningful uses. These efforts allow GVB to compile scientific evidence showing the value of CBG products to regulatory agencies, allowing for efficient access to the marketplace.<\/p>\n<p>GVB Biopharma sets the industry standard for rigor in developing, testing and manufacturing hemp and cannabinoid products for the discerning consumer. With its state-of-the-art facilities for hemp processing in <span class=\"xn-location\">Oregon<\/span> and white-label consumer product manufacturing in <span class=\"xn-location\">Nevada<\/span>, GVB Biopharma sets the standard for product quality. From using rigorous research, to testing the genetic stability of seeds, to verifying the cannabinoid capacity of its plants and purity of the distilled oil, the integrity of the GVB Biopharma process is reflected in every product. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">\n<\/div>\n<p id=\"PURL\"><img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA85464&amp;sd=2020-08-06\"\/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential-301107981.html\">http:\/\/www.prnewswire.com\/news-releases\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential-301107981.html<\/a><\/p>\n<p>SOURCE  GVB Biopharma<\/p>\n<\/div>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA85464&amp;Transmission_Id=202008061500PR_NEWS_USPR_____LA85464&amp;DateId=20200806\" style=\"border:0px; width:1px; height:1px;\"\/> <\/p>","protected":false},"excerpt":{"rendered":"<div class=\"xn-content\">\n<p><span class=\"xn-location\">LAS VEGAS<\/span>, <span class=\"xn-chron\">Aug. 6, 2020<\/span> \/PRNewswire\/ &#8212; GVB Biopharma, a pharmaceutical company specializing in hemp and cannabis-related consumer products, announced today that it has established the process and infrastructure for producing medicinal products from cannabigerol (CBG). This natural cannabinoid is a critical precursor molecule to two well-known cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD).<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n&#8230;<\/p>\n","protected":false},"author":1,"featured_media":12864,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[25],"tags":[],"class_list":["post-12863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-geovanny-vicente"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential - Multisitio 2<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential - Multisitio 2\" \/>\n<meta property=\"og:description\" content=\"LAS VEGAS, Aug. 6, 2020 \/PRNewswire\/ -- GVB Biopharma, a pharmaceutical company specializing in hemp and cannabis-related consumer products, announced today that it has established the process and infrastructure for producing medicinal products from cannabigerol (CBG). This natural cannabinoid is a critical precursor molecule to two well-known cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD).            ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/\" \/>\n<meta property=\"og:site_name\" content=\"Multisitio 2\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-06T15:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wordpress2.hdnweb.com\/wp-content\/uploads\/2020\/05\/12863_1_76712.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1717\" \/>\n\t<meta property=\"og:image:height\" content=\"570\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"venred\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"venred\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/\"},\"author\":{\"name\":\"venred\",\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/#\\\/schema\\\/person\\\/c112e8e970f2cfc8553cdb5392b493ad\"},\"headline\":\"GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential\",\"datePublished\":\"2020-08-06T15:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/\"},\"wordCount\":320,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/12863_1_76712.jpg\",\"articleSection\":[\"Geovanny Vicente\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/\",\"url\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/\",\"name\":\"GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential - Multisitio 2\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/12863_1_76712.jpg\",\"datePublished\":\"2020-08-06T15:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/#\\\/schema\\\/person\\\/c112e8e970f2cfc8553cdb5392b493ad\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[[\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/\"]]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/#primaryimage\",\"url\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/12863_1_76712.jpg\",\"contentUrl\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/12863_1_76712.jpg\",\"width\":1717,\"height\":570,\"caption\":\"GVB Biopharma (PRNewsfoto\\\/GVB Biopharma)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/2020\\\/08\\\/06\\\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/\",\"name\":\"Multisitio 2\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/#\\\/schema\\\/person\\\/c112e8e970f2cfc8553cdb5392b493ad\",\"name\":\"venred\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2b023a883433f83ad0a3036a7ba60d3133c4e0619f3bca6230ba8c7521b6dec8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2b023a883433f83ad0a3036a7ba60d3133c4e0619f3bca6230ba8c7521b6dec8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2b023a883433f83ad0a3036a7ba60d3133c4e0619f3bca6230ba8c7521b6dec8?s=96&d=mm&r=g\",\"caption\":\"venred\"},\"url\":\"https:\\\/\\\/wordpress2.hdnweb.com\\\/en\\\/author\\\/venred\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential - Multisitio 2","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/","og_locale":"en_US","og_type":"article","og_title":"GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential - Multisitio 2","og_description":"LAS VEGAS, Aug. 6, 2020 \/PRNewswire\/ -- GVB Biopharma, a pharmaceutical company specializing in hemp and cannabis-related consumer products, announced today that it has established the process and infrastructure for producing medicinal products from cannabigerol (CBG). This natural cannabinoid is a critical precursor molecule to two well-known cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD).            ...","og_url":"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/","og_site_name":"Multisitio 2","article_published_time":"2020-08-06T15:00:00+00:00","og_image":[{"width":1717,"height":570,"url":"https:\/\/wordpress2.hdnweb.com\/wp-content\/uploads\/2020\/05\/12863_1_76712.jpg","type":"image\/jpeg"}],"author":"venred","twitter_card":"summary_large_image","twitter_misc":{"Written by":"venred","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wordpress2.hdnweb.com\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/#article","isPartOf":{"@id":"https:\/\/wordpress2.hdnweb.com\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/"},"author":{"name":"venred","@id":"https:\/\/wordpress2.hdnweb.com\/#\/schema\/person\/c112e8e970f2cfc8553cdb5392b493ad"},"headline":"GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential","datePublished":"2020-08-06T15:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/wordpress2.hdnweb.com\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/"},"wordCount":320,"commentCount":0,"image":{"@id":"https:\/\/wordpress2.hdnweb.com\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/#primaryimage"},"thumbnailUrl":"https:\/\/wordpress2.hdnweb.com\/wp-content\/uploads\/2020\/05\/12863_1_76712.jpg","articleSection":["Geovanny Vicente"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/","url":"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/","name":"GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential - Multisitio 2","isPartOf":{"@id":"https:\/\/wordpress2.hdnweb.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/#primaryimage"},"image":{"@id":"https:\/\/wordpress2.hdnweb.com\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/#primaryimage"},"thumbnailUrl":"https:\/\/wordpress2.hdnweb.com\/wp-content\/uploads\/2020\/05\/12863_1_76712.jpg","datePublished":"2020-08-06T15:00:00+00:00","author":{"@id":"https:\/\/wordpress2.hdnweb.com\/#\/schema\/person\/c112e8e970f2cfc8553cdb5392b493ad"},"breadcrumb":{"@id":"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":[["https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/"]]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/#primaryimage","url":"https:\/\/wordpress2.hdnweb.com\/wp-content\/uploads\/2020\/05\/12863_1_76712.jpg","contentUrl":"https:\/\/wordpress2.hdnweb.com\/wp-content\/uploads\/2020\/05\/12863_1_76712.jpg","width":1717,"height":570,"caption":"GVB Biopharma (PRNewsfoto\/GVB Biopharma)"},{"@type":"BreadcrumbList","@id":"https:\/\/wordpress2.hdnweb.com\/en\/2020\/08\/06\/gvb-biopharma-begins-cannabigerol-cbg-studies-to-assess-therapeutic-potential\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/wordpress2.hdnweb.com\/en\/"},{"@type":"ListItem","position":2,"name":"GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential"}]},{"@type":"WebSite","@id":"https:\/\/wordpress2.hdnweb.com\/en\/#website","url":"https:\/\/wordpress2.hdnweb.com\/en\/","name":"Multisitio 2","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wordpress2.hdnweb.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/wordpress2.hdnweb.com\/#\/schema\/person\/c112e8e970f2cfc8553cdb5392b493ad","name":"venred","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/2b023a883433f83ad0a3036a7ba60d3133c4e0619f3bca6230ba8c7521b6dec8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2b023a883433f83ad0a3036a7ba60d3133c4e0619f3bca6230ba8c7521b6dec8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2b023a883433f83ad0a3036a7ba60d3133c4e0619f3bca6230ba8c7521b6dec8?s=96&d=mm&r=g","caption":"venred"},"url":"https:\/\/wordpress2.hdnweb.com\/en\/author\/venred\/"}]}},"_links":{"self":[{"href":"https:\/\/wordpress2.hdnweb.com\/en\/wp-json\/wp\/v2\/posts\/12863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wordpress2.hdnweb.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wordpress2.hdnweb.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wordpress2.hdnweb.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wordpress2.hdnweb.com\/en\/wp-json\/wp\/v2\/comments?post=12863"}],"version-history":[{"count":0,"href":"https:\/\/wordpress2.hdnweb.com\/en\/wp-json\/wp\/v2\/posts\/12863\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wordpress2.hdnweb.com\/en\/wp-json\/wp\/v2\/media\/12864"}],"wp:attachment":[{"href":"https:\/\/wordpress2.hdnweb.com\/en\/wp-json\/wp\/v2\/media?parent=12863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wordpress2.hdnweb.com\/en\/wp-json\/wp\/v2\/categories?post=12863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wordpress2.hdnweb.com\/en\/wp-json\/wp\/v2\/tags?post=12863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}